- Home
- IPDN vs NLSP Comparison
IPDN vs NLSP Comparison
Compare IPDN & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- NLSP
- Stock Information
- Founded
- IPDN 2003
- NLSP 2015
- Country
- IPDN United States
- NLSP Switzerland
- Employees
- IPDN N/A
- NLSP N/A
- Industry
- IPDN EDP Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- NLSP Health Care
- Exchange
- IPDN Nasdaq
- NLSP Nasdaq
- Market Cap
- IPDN 11.1M
- NLSP 243.8M
- IPO Year
- IPDN 2013
- NLSP 2021
- Fundamental
- Price
- IPDN $0.89
- NLSP $4.96
- Analyst Decision
- IPDN
- NLSP
- Analyst Count
- IPDN 0
- NLSP 0
- Target Price
- IPDN N/A
- NLSP N/A
- AVG Volume (30 Days)
- IPDN 236.3K
- NLSP 34.6K
- Earning Date
- IPDN 11-12-2024
- NLSP 11-01-2024
- Dividend Yield
- IPDN N/A
- NLSP N/A
- EPS Growth
- IPDN N/A
- NLSP N/A
- EPS
- IPDN N/A
- NLSP N/A
- Revenue
- IPDN $7,319,905.00
- NLSP N/A
- Revenue This Year
- IPDN N/A
- NLSP N/A
- Revenue Next Year
- IPDN N/A
- NLSP N/A
- P/E Ratio
- IPDN N/A
- NLSP N/A
- Revenue Growth
- IPDN N/A
- NLSP N/A
- 52 Week Low
- IPDN $0.42
- NLSP $4.08
- 52 Week High
- IPDN $3.01
- NLSP $29.68
- Technical
- Relative Strength Index (RSI)
- IPDN 59.33
- NLSP 46.37
- Support Level
- IPDN $0.77
- NLSP $4.52
- Resistance Level
- IPDN $0.97
- NLSP $5.64
- Average True Range (ATR)
- IPDN 0.14
- NLSP 0.48
- MACD
- IPDN -0.00
- NLSP 0.07
- Stochastic Oscillator
- IPDN 35.95
- NLSP 55.44
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.